DXP ENTERPRISES INC
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(in thousands, except per share amounts) (unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Sales | $412,635 | $424,267 |
| Cost of sales | 288,753 | 299,226 |
| Gross profit | 123,882 | 125,041 |
| Selling, general and administrative expenses | 94,751 | 89,642 |
| Income from operations | 29,131 | 35,399 |
| Other income, net | (1,968) | (469) |
| Interest expense | 15,544 | 11,521 |
| Income before income taxes | 15,555 | 24,347 |
| Provision for income taxes | 4,223 | 6,767 |
| Net income | 11,332 | 17,580 |
| Preferred stock dividend | 23 | 23 |
| Net income attributable to common shareholders | $11,309 | $17,557 |
| Net income | $11,332 | $17,580 |
| Foreign currency translation adjustments | (614) | 98 |
| Comprehensive income | $10,718 | $17,678 |
| Earnings per share (Note 9): | ||
| Basic | $0.70 | $1.00 |
| Diluted | $0.67 | $0.95 |
| Weighted average common shares outstanding: | ||
| Basic | 16,128 | 17,596 |
| Diluted | 16,968 | 18,436 |
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts) (unaudited)
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash | $139,697 | $173,120 |
| Restricted cash | 91 | 91 |
| Accounts receivable, net of allowance of $4,946 and $5,584, respectively | 313,791 | 311,171 |
| Inventories | 108,186 | 103,805 |
| Costs and estimated profits in excess of billings | 35,259 | 42,323 |
| Prepaid expenses and other current assets | 19,808 | 18,044 |
| Total current assets | 616,832 | 648,554 |
| Property and equipment, net | 64,039 | 61,618 |
| Goodwill | 370,949 | 343,991 |
| Other intangible assets, net | 67,675 | 63,895 |
| Operating lease right of use assets, net | 53,443 | 48,729 |
| Other long-term assets | 11,217 | 10,649 |
| Total assets | $1,184,155 | $1,177,436 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Current maturities of debt | $5,500 | $5,500 |
| Trade accounts payable | 97,324 | 96,469 |
| Accrued wages and benefits | 31,655 | 36,238 |
| Customer advances | 12,619 | 12,160 |
| Billings in excess of costs and estimated profits | 8,195 | 9,506 |
| Short-term operating lease liabilities | 15,796 | 15,438 |
| Other current liabilities | 58,313 | 48,854 |
| Total current liabilities | 229,402 | 224,165 |
| Long-term debt, net of unamortized debt issuance costs and discounts | 520,217 | 520,697 |
| Long-term operating lease liabilities | 38,914 | 34,336 |
| Other long-term liabilities | 20,158 | 17,359 |
| Total long-term liabilities | 579,289 | 572,392 |
| Total liabilities | 808,691 | 796,557 |
| Commitments and Contingencies (Note 10) | ||
| Shareholders' equity: | ||
| Series A preferred stock, $1.00 par value; 1,000,000 shares authorized | 1 | 1 |
| Series B preferred stock, $1.00 par value; 1,000,000 shares authorized | 15 | 15 |
| Common stock, $0.01 par value, 100,000,000 shares authorized; 15,928,305 and 16,177,237 outstanding, respectively | 345 | 345 |
| Additional paid-in capital | 217,292 | 216,482 |
| Retained earnings | 330,580 | 319,271 |
| Accumulated other comprehensive loss | (31,854) | (31,240) |
| Treasury stock, at cost 4,468,354 and 4,141,989 shares, respectively | (140,915) | (123,995) |
| Total DXP Enterprises, Inc. equity | 375,464 | 380,879 |
| Total liabilities and equity | $1,184,155 | $1,177,436 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands) (unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income | 11,332 | 17,580 |
| Reconciliation of net income to net cash provided by operating activities: | ||
| Depreciation | 2,208 | 2,024 |
| Amortization of intangibles and fixed assets | 5,330 | 4,758 |
| (Recovery of) provision for credit losses | (1,200) | 498 |
| Payment of contingent consideration liability in excess of acquisition-date fair value | (17) | — |
| Fair value adjustment on contingent consideration | (194) | 342 |
| Amortization of debt issuance costs | 895 | 642 |
| Restricted stock compensation expense | 864 | 476 |
| Deferred income taxes | (3,056) | (2,799) |
| Changes in operating assets and liabilities, net of effects of businesses acquired: | ||
| Accounts receivable, net | 8,993 | 9,070 |
| Costs and estimated profits in excess of billings | 7,052 | (18,378) |
| Accounts payable and accrued expenses | (2,165) | 13,311 |
| Prepaid expenses and other assets | 3,366 | 8,844 |
| Inventories | 754 | (8,006) |
| Billings in excess of costs and estimated profits | (1,301) | (231) |
| Other long-term liabilities | (5,872) | (1,682) |
| Net cash provided by operating activities | $26,989 | $26,449 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of property and equipment | (2,894) | (3,804) |
| Acquisition of businesses, net of cash acquired | (39,261) | — |
| Net cash used in investing activities | $(42,155) | $(3,804) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Repayments under term loan facility | (1,375) | (1,092) |
| Payment for acquisition contingent consideration liability | (983) | — |
| Preferred stock dividends paid | (23) | (23) |
| Shares repurchased held in treasury | (14,815) | (9,135) |
| Payment for employee taxes withheld from stock awards | (54) | (104) |
| Principal payments on finance leases | (896) | — |
| Net cash used in financing activities | $(18,146) | $(10,354) |
| Effect of foreign currency on cash | (111) | (35) |
| Net change in cash and restricted cash | (33,423) | 12,256 |
| Cash and restricted cash at beginning of period | 173,211 | 46,117 |
| Cash and restricted cash at end of period | $139,788 | $58,373 |
| Supplemental cash flow information (Note 14) | ||
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands) (unaudited)
| Series A preferred stock | Series B preferred stock | Common stock | Paid-in capital | Retained earnings | Treasury stock | Accum other comp loss | Total equity | |
|---|---|---|---|---|---|---|---|---|
| Balance at December 31, 2023 | $1 | $15 | $345 | $216,482 | $319,271 | $(123,995) | $(31,240) | $380,879 |
| Preferred dividends paid | — | — | — | — | (23) | — | — | (23) |
| Compensation expense for restricted stock | — | — | — | 864 | — | — | — | 864 |
| Tax related items for share based awards | — | — | — | (54) | — | — | — | (54) |
| Currency translation adjustment | — | — | — | — | — | — | (614) | (614) |
| Repurchases of shares | — | — | — | — | — | (16,920) | — | (16,920) |
| Net income | — | — | — | — | 11,332 | — | — | 11,332 |
| Balance at March 31, 2024 | $1 | $15 | $345 | $217,292 | $330,580 | $(140,915) | $(31,854) | $375,464 |
| Series A preferred stock | Series B preferred stock | Common stock | Paid-in capital | Retained earnings | Treasury stock | Accum other comp loss | Total equity | |
|---|---|---|---|---|---|---|---|---|
| Balance at December 31, 2022 | $1 | $15 | $345 | $213,937 | $250,549 | $(67,780) | $(31,675) | $365,392 |
| Preferred dividends paid | — | — | — | — | (23) | — | — | (23) |
| Compensation expense for restricted stock | — | — | — | 476 | — | — | — | 476 |
| Tax related items for share based awards | — | — | — | (104) | — | — | — | (104) |
| Currency translation adjustment | — | — | — | — | — | — | 98 | 98 |
| Repurchases of shares | — | — | — | — | — | (9,135) | — | (9,135) |
| Net income | — | — | — | — | 17,580 | — | — | 17,580 |
| Balance at March 31, 2023 | $1 | $15 | $345 | $214,309 | $268,106 | $(76,915) | $(31,577) | $374,284 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 -THE COMPANY
DXP Enterprises, Inc. together with its subsidiaries (collectively "DXP," the "Company," "us," "we," or "our") was incorporated in Texas on July 26, 1996. DXP Enterprises, Inc. and its subsidiaries are engaged in the business of distributing maintenance, repair and operating ("MRO") products and services to a variety of end markets and business-to-business customers. Additionally, DXP provides integrated, custom pump skid packages, pump remanufacturing and manufactures branded private label pumps to energy and broad industrial customers. The Company is currently organized into three business segments: Service Centers ("SC"), Innovative Pumping Solutions ("IPS"), and Supply Chain Services ("SCS"). See Note 11 - Segment Reporting for discussion of the business segments.
NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING AND BUSINESS POLICIES
Basis of Presentation
The Company's financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). For interim financial reporting not all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP are required. The unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2023 that are included in our annual report on Form 10-K filed with the SEC on March 11, 2024 (“Annual Report”).
The results of operations for the three months ended March 31, 2024 are not necessarily indicative of results expected for the full fiscal year. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for the fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented.
All intercompany accounts and transactions have been eliminated in consolidation.
NOTE 3 -RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
The Company considers the applicability and impact of all Accounting Standard Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not listed within this Quarterly Report on Form 10-Q were assessed and determined as either not applicable or not material to the Company’s consolidated financial position or result of operations.
NOTE 4 -FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES
Our acquisitions may include contingent consideration as part of the purchase price. The fair value of the contingent consideration is estimated as of the acquisition date based on the present value of the contingent payments to be made using a weighted probability of possible payments. The unobservable inputs used in the determination of the fair value of the contingent consideration include management's assumptions about the likelihood of payment based on the established benchmarks, discount rates, and an internal rate of return analysis. The fair value measurement includes inputs that are Level 3 inputs as they are not observable in the market. Should actual results increase or decrease as compared to the assumptions used in our analysis, the fair value of the contingent consideration obligations will increase or decrease, up to the contracted limit, as applicable. Changes in the fair value of the contingent consideration are measured each reporting period and reflected in our results of operations.
As of March 31, 2024, we recorded $6.1 million in other current and other long-term liabilities for contingent consideration associated with the recent acquisitions.
The following table provides a reconciliation of the beginning and ending balances and gains or losses recognized during the three months ended March 31, 2024 (in thousands):
| Contingent Consideration | |
|---|---|
| *Beginning balance at December 31, 2023 | $8,753 |
| Acquisitions (Note 12) | 6,108 |
| Settlements | (1,000) |
| Total remeasurement adjustments: | |
| Changes in fair value recorded in other income, net | (194) |
| *Ending Balance at March 31, 2024 | $13,667 |
| *Amounts included in other current liabilities were $8.1 million and $5.4 million for the periods ending March 31, 2024 and December 31, 2023, respectively. Amounts included in other long-term liabilities were $5.6 million and $3.4 million for the periods ending March 31, 2024 and December 31, 2023, respectively. | |
Sensitivity to Changes in Significant Unobservable Inputs
The significant Level 3 unobservable inputs used in the fair value measurement of contingent consideration related to the acquisitions are annualized EBITDA forecasts developed by the Company's management and the probability of achievement of those EBITDA results. The discount rate used in the calculations was 10.6 percent. Changes in our unobservable inputs in isolation would result in a change to our fair value measurement. As of March 31, 2024, the maximum amount of contingent consideration payable under these arrangements is $17.5 million.
Other financial instruments not measured at fair value on the Company's unaudited condensed consolidated balance sheets at March 31, 2024 and December 31, 2023, but which require disclosure of their fair values include: cash, restricted cash, accounts receivable, trade accounts payable and accrued expenses. The Company believes that the estimated fair value of such instruments at March 31, 2024 and December 31, 2023 approximates their carrying value as reported on the unaudited condensed consolidated balance sheets due to the relative short maturity of these instruments. See Note 8 - Long-term Debt for fair value disclosures on our asset-backed line of credit and term loan debt under our syndicated credit agreement facilities.
NOTE 5 –INVENTORIES
Inventories are made up of equipment purchased for resale, and materials utilized in the fabrication of industrial and wastewater equipment stated at lower of cost and net realizable value, primarily determined using the weighted average cost method. The Company reviews inventory and records provisions for the difference between cost and net realizable value arising from excess and obsolete items on hand based upon the aging of the inventories, market trends, and continued demand.
The carrying values of inventories are as follows (in thousands):
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| Finished goods | $96,999 | $94,031 |
| Work in process | 11,187 | 9,774 |
| Inventories | $108,186 | $103,805 |
NOTE 6 –CONTRACT ASSETS AND LIABILITIES
Under our customized pump production and water and wastewater project contracts, amounts are billed as work progresses in accordance with agreed-upon contractual terms, upon various measures of performance, including achievement of certain milestones, completion of specified units, or completion of a contract. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets presented as "Costs and estimated profits in excess of billings". However, we sometimes receive advances or deposits from our customers before revenue is recognized, resulting in contract liabilities that are presented as “Billings in excess of costs and estimated profits” on our unaudited condensed consolidated balance sheets.
Costs and estimated profits on uncompleted contracts and related amounts billed were as follows (in thousands):
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| Costs incurred on uncompleted contracts | $91,469 | $92,363 |
| Estimated profits, thereon | 40,099 | 37,379 |
| Total costs and estimated profits on uncompleted contracts | 131,568 | 129,742 |
| Less: billings to date | 104,504 | 96,928 |
| Net | $27,064 | $32,814 |
Such amounts were included in the accompanying unaudited condensed consolidated balance sheets for March 31, 2024 and December 31, 2023 under the following captions (in thousands):
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| Costs and estimated profits in excess of billings | $35,259 | $42,323 |
| Billings in excess of costs and estimated profits | (8,195) | (9,506) |
| Translation adjustment | — | (3) |
| Net | $27,064 | $32,814 |
During the three months ended March 31, 2024 and 2023, $1.4 million and $9.7 million of the balances that were previously classified as contract liabilities at the beginning of the period were recognized in revenues, respectively. Contract asset and liability changes were primarily due to normal activity and timing differences between our performance and customer payments.
NOTE 7 –INCOME TAXES
Income tax expense during interim periods is based on our estimated annual effective income tax rate plus any discrete items, which are recorded in the period in which they occur. Our effective tax rate from continuing operations was a tax expense of 27.2 percent for the three months ended March 31, 2024 compared to a tax expense of 27.9 percent for the three months ended March 31, 2023. Compared to the U.S. statutory rate for the three months ended March 31, 2024, the effective tax rate was increased by state taxes, foreign taxes, nondeductible expenses, earnout payments, and uncertain tax positions recorded for research and development tax credits and was partially offset by research and development tax credits and other tax credits.
To the extent penalties and interest would be assessed on any underpayment of income tax, such accrued amounts would be classified as a component of income tax provision (benefit) in the financial statements consistent with the Company’s policy.
The Organization of Economic Cooperation and Development (OECD) continues to release additional guidance, including administrative guidance on how Pillar Two rules should be interpreted and applied by jurisdictions as they adopt Pillar Two. A number of countries have utilized the administrative guidance as a starting point for legislation that went into effect January 1, 2024. As of March 31, 2024 DXP anticipates the impact of Pillar Two to be immaterial to the Company based on current legislation that has been enacted to date.
NOTE 8 –LONG-TERM DEBT
The components of the Company's long-term debt consisted of the following (in thousands):
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| ABL Revolver | $— | $— |
| Senior Secured Term Loan B due October 13, 2030(1) | 547,250 | 548,625 |
| Total debt | 547,250 | 548,625 |
| Less: current maturities | (5,500) | (5,500) |
| Total long-term debt | $541,750 | $543,125 |
| Unamortized discount and debt issuance costs | 21,533 | 22,428 |
| Long-term debt, net of unamortized discount and debt issuance costs | $520,217 | $520,697 |
(1) The fair value of the Term Loan B due October 13, 2030 was $551.4 million and $554.1 million as of March 31, 2024 and December 31, 2023, respectively.
Senior Secured Term Loan B:
On October 13, 2023, the Company entered into an amendment on its existing Senior Secured Term Loan B (the "Term Loan Amendment"), which provides for, among other things, an additional $125 million in new incremental commitments. The Term Loan Amendment refinanced the existing Senior Term Loan B and replaced it with a new Senior Secured Term Loan B with total borrowings of $550.0 million. The new Senior Secured Term Loan B amortizes in equal quarterly installments of 0.25%, with the remaining balance being payable on October 13, 2030, when the facility matures.
Deferred financing costs associated with the Term Loan Amendment were $11.7 million, which is being amortized to interest expense using the interest method over the remaining maturity of the Senior Secured Term Loan B. The interest rate for the Senior Secured Term Loan B was 10.29% and 10.44% as of March 31, 2024 and December 31, 2023, respectively.
In connection with the Term Loan Amendment the Company expensed third-party fees of $0.8 million and recognized a $1.2 million loss on debt extinguishment, which were included in interest expense during 2023. Quarterly interest payments accrue on outstanding borrowings under the new Senior Secured Term Loan B at a rate equal to Term SOFR (with a floor of 1.00%) plus 4.75%, or base rate plus 3.75%. The new Senior Secured Term Loan B is guaranteed by each of the Company’s direct and indirect material wholly owned subsidiaries, other than any of the Company’s Canadian subsidiaries and certain other excluded subsidiaries.
As of March 31, 2024 there was $547.3 million outstanding under the Senior Secured Term Loan B.
ABL Revolver:
On July 19, 2022, the Company entered into an Amended and Restated Loan and Security Agreement (the “ABL Credit Agreement”) that provided for a $135.0 million asset-backed revolving line of credit (the "ABL Revolver"). Subject to the conditions set forth in the ABL Credit Agreement, the ABL Revolver may be increased in increments of $10.0 million up to an aggregate of $50.0 million. The ABL Revolver matures on July 19, 2027. Interest accrues on outstanding borrowings at a rate equal to SOFR plus a margin ranging from 1.25% to 1.75% per annum, or at an alternate base rate, Canadian prime rate or Canadian base rate plus a margin ranging from 0.25% to 0.75% per annum, in each case, based upon the average daily excess availability under the ABL Revolver for the most recently completed calendar quarter. Fees payable on the unused portion of the facility range from 0.25% to 0.375% per annum. At March 31, 2024 the unused line fee was 0.375% and there wereno amounts outstanding under the ABL Revolver.
As of March 31, 2024, the borrowing availability under our credit facility was $131.8 million compared to $132.1 million at December 31, 2023, primarily as a result of outstanding letters of credit.
The interest rate for the ABL Revolver was 8.75% as of March 31, 2024 and December 31, 2023, respectively.
Financial Covenants:
The Company's principal financial covenants under the ABL Credit Agreement and Term Loan B Agreement include:
Fixed Charge Coverage Ratio – The Fixed Charge Coverage Ratio under the ABL Credit Agreement is defined as the ratio for the most recently completed four-fiscal quarter period, of (a) EBITDA minus capital expenditures (excluding (i) those financed or funded with debt (other than the ABL Loans), (ii) the portion thereof funded with the net proceeds from asset dispositions of equipment or real property which the Company is permitted to reinvest pursuant to the Term Loan and (iii) the portion thereof funded with the net proceeds of casualty insurance or condemnation awards in respect of any equipment and real estate which DXP is not required to use to prepay the ABL Loans pursuant to the Term Loan B Agreement or with the proceeds of casualty insurance or condemnation awards in respect of any other property)minus cash taxes paid (net of cash tax refunds received during such period), to (b) fixed charges. The Company is restricted from allowing its fixed charge coverage ratio to be less than 1.00 to 1.00 during a compliance period, which is triggered when the availability under the ABL Revolver falls below a threshold set forth in the ABL Credit Agreement.
As of March 31, 2024, the Company's Fixed Charge Coverage Ratio was 2.28 to 1.00.
Secured Leverage Ratio – The Term Loan B Agreement requires that the Company’s Secured Leverage Ratio, defined as the ratio, as of the last day of any fiscal quarter of consolidated secured debt (net of unrestricted cash, not to exceed $200 million) as of such day to EBITDA, beginning with the fiscal quarter ending March 31, 2024, is either equal to or less than as indicated in the table below:
| Fiscal Quarter | Secured Leverage Ratio |
|---|---|
| March 31, 2024 | 5.75:1.00 |
| June 30, 2024 | 5.50:1.00 |
| September 30, 2024 | 5.50:1.00 |
| December 31, 2024 | 5.50:1.00 |
| March 31, 2025 | 5.25:1.00 |
| June 30, 2025 | 5.25:1.00 |
| September 30, 2025 | 5.25:1.00 |
| December 31, 2025 | 5.00:1.00 |
| March 31, 2026 | 5.00:1.00 |
| June 30, 2026 and thereafter | 4.75:1.00 |
As of March 31, 2024, the Company’s Secured Leverage Ratio was 2.27 to 1.00.
EBITDA as defined under the Term Loan B Agreement for financial covenant purposes means, without duplication, for any period of determination, the sum of, consolidated net income during such period; plus to the extent deducted from consolidated net income in such period: (i) income tax expense, (ii) franchise tax expense, (iii) interest expense, (iv) amortization and depreciation during such period, (v) all non-cash charges and adjustments, and (vi) non-recurring cash expenses related to the Term Loan, provided, that if the Company acquires or disposes of any property during such period (other than under certain exceptions specified in the Term Loan B Agreement, including the sale of inventory in the ordinary course of business), then EBITDA shall be calculated, after giving pro forma effect to such acquisition or disposition, as if such acquisition or disposition had occurred on the first day of such period.
The Company was in compliance with all financial covenants as of March 31, 2024.
As of March 31, 2024, the maturities of long-term debt for the next five years and thereafter were as follows (in thousands):
| Amount | |
|---|---|
| 2024 | $4,125 |
| 2025 | 5,500 |
| 2026 | 5,500 |
| 2027 | 5,500 |
| 2028 | 5,500 |
| Thereafter | 521,125 |
| Total | $547,250 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.